Forte Biosciences, Inc. (FBRX)
20.07
-0.90
(-4.29%)
USD |
NASDAQ |
May 19, 16:00
20.01
-0.06
(-0.30%)
After-Hours: 20:00
Forte Biosciences Total Liabilities (Quarterly) : 25.12M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Agenus, Inc. | 414.44M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
| Anika Therapeutics, Inc. | 45.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 67.22M |
| Shareholders Equity (Quarterly) | 42.10M |
| Current Ratio | 2.753 |